[EN] CYCLOALKYL-FUSED TETRAHYDROQUINOLINES AS CRTH2 RECEPTOR MODULATORS<br/>[FR] TÉTRAHYDROQUINOLINES À FUSION CYCLOALKYLE EN TANT QUE MODULATEURS DE L'ACTIVITÉ DU RÉCEPTEUR CRTH2
申请人:MERCK SHARP & DOHME
公开号:WO2012174176A1
公开(公告)日:2012-12-20
The invention provides certain cycloalkyl-fused tetrahydroquinolines of the Formula (I), and their pharmaceutically acceptable salts and esters, wherein R1, R2, R7, R8, R8a, E, Y, Z, n, u, and t are as defined herein. The invention also provides pharmaceutical compositions comprising such compounds, and methods of using the compounds for treating diseases or conditions associated with with uncontrolled or inappropriate stimulation of CRTH2 function.
该发明提供了某些公式(I)中的环烷基融合四氢喹啉化合物,以及它们的药用盐和酯,其中R1、R2、R7、R8、R8a、E、Y、Z、n、u和t的定义如本文所述。该发明还提供了包括这些化合物的药物组合物,以及使用这些化合物用于治疗与CRTH2功能的不受控制或不适当刺激相关的疾病或病况的方法。